Toggle navigation
Home
Search
Services
Blog
Contact
About
Early Therapeutics Development with Phase 2 Emphasis-261017101
University of California Sys Office/Pres, Oakland, CA, United States
Search grants from University of California Sys Office/Pres
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
University of California San Francisco
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
CD8+ T cells and Immunological Tumor Regression
Astrocyte Activation, Dysfunction &Apoptosis in HAD
Function of Mammalian Premrna Splicing Factors
Grants for Faculty Development in Family Medicine
Binocular Vision and Depth Perception
Recently added grants:
Novel randomized controlled trials of vitamin D supplementation in patients with colorectal cancer: Impact on survival and biology
Mechanisms of AR-Er Collaboration in Hormone Resistance and Metastasis of Breast Cancer
Role of PD2/Paf1 in Pancreatic Acinar to Ductal Metaplasia
Therapeutic use of HPV L1 Vaccine in Anogenital Neoplasia: VIVA Trial
Cytoplasmic cyclin E is an early event for progression to invasive breast cancer
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CA017101-002
Application #
6688650
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2002
Total Cost
Indirect Cost
Institution
Name
University of California Sys Office/Pres
Department
Type
DUNS #
003985512
City
Oakland
State
CA
Country
United States
Zip Code
94607
Related projects
NIH 2005
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017101
/ University of California Sys Office/Pres
NIH 2004
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017101
/ University of California Sys Office/Pres
NIH 2003
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017101
/ University of California Sys Office/Pres
NIH 2002
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017101
/ University of California Sys Office/Pres
Comments
Be the first to comment on this grant